Helicobacter Pylori Diagnostics Market IS Expected To Witness A CAGR of 7.1% Over The Forecast Period 2018–2026 | Top Players Thermo Fisher Scientific, Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Diasorin S.P.A.

Helicobacter is a spiral shaped gram-negative bacteria, causing chronic inflammation and infection in stomach and duodenum leading to ulceration. H. pylori is found in 50-80% of patients with gastric ulcers and in 90% of patients with duodenal ulcers. An estimated one in six individuals infected with H. pylori are expected to eventually develop peptic ulcer disease. Infected individuals experience long asymptomatic conditions with nearly 70% of individuals having minimal symptoms such as belching, bloating, nausea, vomiting, abdominal discomfort as occasional, whereas, major symptoms includes abdominal pain, peptic ulcer, bad breath etc. Helicobacter infection can be diagnosed by invasive that requires gastric mucosa samples, which are obtained through endoscopy and used for biopsy or non-invasive tests that requires blood or stool samples. Invasive tests include immunoassay, rapid urease test, and histology whereas non-invasive includes stool antigen assays serology tests and urea breath test.

The global Helicobacter pylori diagnostics market size was valued at US$ 437.3 million in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).

Get In-Depth Sample Copy of Research @ https://bit.ly/2GUyHF8

Increasing prevalence of helicobacter pylori in emerging economies is propelling the Helicobacter pylori diagnostics market growth

Prevalence of helicobacter pylori is declining in developed countries, whereas its prevalence in emerging economies is increasing. For instance, according to the Faculty of Medicine of The Chinese University of Hong Kong (CUHK), 2017, around 4.4 billion people worldwide are infected with Helicobacter pylori (H. pylori). Furthermore, same source suggested that prevalence in Africa is up to 80%, which is the highest globally, while in Asia, over 50% of the population was infected with H. pylori. Moreover, according to the International Agency for Research on Cancer report 2014, in 2012, around 952,000 new gastric cancer cases occurred globally and around 734,000 gastric cancers were estimated to occur due to H. pylori infection. Such high prevalence of Helicobacter pylori in Africa and Asia is expected to fuel the regional helicobacter market growth.

Africa market to exhibit fastest growth over the forecast period

Regionally, Helicobacter pylori diagnostics market is segmented into - North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. North America Helicobacter pylori diagnostic market holds dominant position in the global market and this is attributed to initiatives to provide test kits at low costs to eradicate H. pylori infection. For instance, antibody-based detection tests are available at lower cost for enhancing the eradication of helicobacter pylori infection in Quebec. Moreover, Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS), an independent body reporting to the Quebec Minister of Health and Social Services, recommends the 13C-urea breath test to be made available in all areas of Québec. However, Africa Helicobacter pylori diagnostic market is expected to exhibit high CAGR, owing to high prevalence of Helicobacter pylori. According to studies published in Gastroenterology Journal, 2017, the data suggested that Africa has highest prevalence of H. pylori infection, which is around 79%.

Inorganic strategies by key players is fuelling growth of the Helicobacter pylori diagnostics market

Key players involved in the global Helicobacter pylori diagnostics market include

1. Thermo Fisher Scientific, Inc.
2. Bio-Rad Laboratories Inc.
3. Diasorin S.P.A.
4. Quidel Corporation
5. F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.)
6. Meridian Bioscience, Inc.
7. Exalenz Bioscience Ltd.
8. Abbott Laboratories
9. Cardinal Health, Inc.
10. Halyard Health, Inc.

Detailed Segmentation:

By Test Type: Invasive, Immunoassay, Rapid Urease Test, Histology, Non-invasive, Stool Antigen Assays, Serology Tests, Urea Breath Test

By End User: Hospitals, Clinics, Diagnostic Laboratories, Others

By Region: North America, Latin America, Europe, Asia Pacific, Middle East, Africa

Else place an Inquire before Purchase “Global Helicobacter Pylori Diagnostics Market Size, Status and Forecast 2026": https://bit.ly/2T87QvO

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.